Fox Chase Cancer Center News

 Joan Font-Burgada, PhD
October 10, 2018

Scientists Identify Genetically Accurate Mouse Models in Hepatocellular Carcinoma

PHILADELPHIA (October 10, 2018)— Using a detailed analysis comparing the genetic and molecular makeup of tumors from nearly 1,000 patients with four common mouse models of hepatocellular carcinoma (HCC), researchers have identified animal models that most closely mimic human disease. 

October 4, 2018

Professor Jose Russo Honored with Hispanic Heritage Award

PHILADELPHIA (October 4, 2018) – Jose Russo, MD, FACP, director of the Irma H. Russo, MD, Breast Cancer Research Lab at Fox Chase Cancer Center, named by AL DÍA as one of nine recipients of their Hispanic Heritage Award for 2018.
October 2, 2018

Discovery of New Form of Cell Death Offers Clues to Controlling Bacterial Colonization in the Gut

PHILADELPHIA (October 2, 2018) — Observing how cells of the intestinal epithelium respond to Salmonella, scientists at Fox Chase Cancer Center have found a novel mechanism of cell death that shows a way to control the spread of bacteria.

October 2, 2018

Fox Chase Cancer Center Proudly Supports Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia 2018

PHILADELPHIA (October 2, 2018) – Fox Chase Cancer Center will again field a team  to raise funds at the Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia. The event will be held on Saturday, November 3 at Memorial Hall in Fairmount Park.

October 1, 2018

Fox Chase Cancer Center Reminds Women to Schedule a Breast Cancer Screening

PHILADELPHIA (October 1, 2018) – October is Breast Cancer Awareness month. Fox Chase Cancer Center reminds women to schedule their screening test for breast cancer—the most reliable way to detect breast cancer early, when the disease is most treatable.

September 28, 2018

New Patents Earned by Fox Chase Cancer Center in Fiscal Years 2017 and 2018

Philadelphia (September 28, 2018) – Fox Chase Cancer Center is pleased to announce that its scientists and clinicians earned several newly issued patents during fiscal years 2017 and 2018, the latter of which ended June 30, 2018.

Dr. Neil Johnson
September 25, 2018

BRCA1 Mutations Influence Therapy Resistance Mechanisms in Breast and Ovarian Cancers

PHILADELPHIA (September 25, 2018)— In addition to impacting cancer risk, mutations in the BRCA1 gene also have a role in determining whether a patient responds to certain types of therapies. In a new publication, Neil Johnson, PhD, found that cancers with different types of BRCA1 mutations have varying susceptibilities to biological pathways that induce resistance to PARP inhibitors, an emerging class of cancer drugs

Alexander Kutikov, MD, FACS
September 24, 2018

Fox Chase Physician Wins Statewide ‘Everyday Hero’ Award

PHILADELPHIA (August 23, 2018) – Alexander Kutikov, MD, FACS, chief, Division of Urology and Urologic Oncology at Fox Chase Cancer Center, has been named August’s Everyday Hero by the Pennsylvania Medical Society (PAMED). The award is designed to showcase talented physicians who probably don’t view themselves as heroes, but to patients and colleagues they are.


Connect with Fox Chase